A Point-of-Care Paper-based Fingerstick Transaminase Test: Toward Low-cost “Lab-on- a-Chip” Technology for the Developing World  Nira R. Pollock, Donn.

Slides:



Advertisements
Similar presentations
The Role of Psychosocial Care in Adapting to Health Care Reform
Advertisements

Abnormal Liver Tests and Fatty Liver on Ultrasound
Thrombocytopenia With Abnormal Liver Function Tests
Incorrect Calculation and Inappropriate Interpretation: Accuracy of International Guidelines for Identifying Significant Fibrosis in e Antigen–Negative.
Noncardiac Chest Pain Clinical Gastroenterology and Hepatology
Ruben Hernaez, MD, MPH, PhD  Clinical Gastroenterology and Hepatology 
Value of Spatiotemporal Representation of Manometric Data
Pichamol Jirapinyo, Christopher C. Thompson 
Michael Camilleri, Anthony Lembo, David A. Katzka 
Gauree Gupta, Ebbing Lautenbach, James D. Lewis 
Raymond Vlacancich, Mohamed Sultan, Firas Al–Kawas 
A Shocking Cystory Clinical Gastroenterology and Hepatology
Colonic Amyloidosis Clinical Gastroenterology and Hepatology
Brian W. Sipe, Mark Scheidler, Arthur Baluyut, Betty Wright 
Maged K. Rizk, James Merlino, Ashish Atreja 
Lauren A. Beste, George N. Ioannou, Yin Yang, Michael F
Amit G. Singal, Jasmin A. Tiro, Samir Gupta 
Stephen A. Harrison, MD, FACP  Clinical Gastroenterology and Hepatology 
Short-Bowel Syndrome Clinical Gastroenterology and Hepatology
Amnon Sonnenberg, MD, MSc, Brent Y. Lee, MD 
Endocuff to Improve Adenoma Detection: Supported by Low-Quality Evidence or Not Supported by High-Quality Evidence?  Yao Zhang, MD, Sheng-Bing Zhao, MD 
Granular Cell Tumor in Colonic Polyp Found on Screening Colonoscopy
Giant Cell Tumor of the Common Bile Duct
Gastrointestinal Complications of Cystic Fibrosis
Jessica L. Mellinger, Michael L. Volk 
Interpreting Hepatitis B Surface Antigen Levels: Useful Clinical Test or Just Another Confusing Assay?  Brian J. McMahon, MD, Brenna C. Simons, PhD  Clinical.
Joel E. Richter  Clinical Gastroenterology and Hepatology 
Activity-Based Costing and Management in a Hospital-Based GI Unit
May Min, Jason Ferreira, Charles Wang 
Endoscopic Therapy for Barrett's Esophagus
Amie L. Harvey, Tommy Yen, Anand Kunda 
Michel I. Kafrouni, Robert A. Anders, Sumita Verma 
When Should Screening Stop for Elderly Individuals at Average and Increased Risk for Colorectal Cancer?  Folasade P. May, Samir Gupta  Clinical Gastroenterology.
Obstructive Jaundice Caused by Intraductal Hepatocellular Carcinoma
Endoscopic Duodenal–Jejunal Bypass Liner Rapidly Improves Plasma Parameters of Nonalcoholic Fatty Liver Disease  Charlotte de Jonge, Sander S. Rensen,
Abnormal Liver Tests and Fatty Liver on Ultrasound
Gastroenterology in a New Era of Accountability: Part 2
New Models of Gastroenterology Practice
Issue Highlights Clinical Gastroenterology and Hepatology
A 53-Year-Old Woman With Recurrent Vomiting and Migraine Headache
Seema S. Aceves  Clinical Gastroenterology and Hepatology 
David H. Bruining, William J. Sandborn 
Histologic Changes in Liver Tissue From Patients With Chronic Hepatitis B and Minimal Increases in Levels of Alanine Aminotransferase: A Meta-analysis.
Effect of a Time-Dependent Colonoscopic Withdrawal Protocol on Adenoma Detection During Screening Colonoscopy  Robert L. Barclay, Joseph J. Vicari, Roger.
Patient-Reported Outcomes of Cirrhosis
A Young Woman With Gallstone Pancreatitis and Abnormal Liver Tests: When Is Endoscopic Retrograde Cholangiopancreatography Needed?  Andrew D. Rhim, Michael.
Issue Highlights Clinical Gastroenterology and Hepatology
Effects of Different Coping Strategies on Physical and Mental Health of Patients With Irritable Bowel Syndrome  Lilian Dindo, PhD  Clinical Gastroenterology.
Heiko Pohl, Douglas J. Robertson 
Issue Highlights Clinical Gastroenterology and Hepatology
Initiating Azathioprine for Crohn's Disease
Suna Yapali, MD, Anna S. Lok, MD, FRCP 
Hannah I. Awai, Kimberly P. Newton, Claude B
Michael L. Volk, MD, MSc, AGAF 
Issue Highlights Clinical Gastroenterology and Hepatology
Hepatic Cyst? Clinical Gastroenterology and Hepatology
Thrombocytopenia With Abnormal Liver Function Tests
Predictors of Early Treatment Discontinuation Among Patients With Genotype 1 Hepatitis C and Implications for Viral Eradication  Lauren A. Beste, George.
Hepatitis C Virus Infection, Age, and Hispanic Ethnicity Increase Mortality From Liver Cancer in the United States  Zobair M. Younossi, Maria Stepanova 
Substantial Variability in Biopsy Practice Patterns Among Gastroenterologists for Suspected Eosinophilic Gastrointestinal Disorders  Evan S. Dellon, MD,
A 27-Year-Old Woman With Constipation: Diagnosis and Treatment
Management of Hepatitis B
Clinical Gastroenterology and Hepatology
Coagulation in Liver Disease: A Guide for the Clinician
Issue Highlights Clinical Gastroenterology and Hepatology
Black and White Liver Clinical Gastroenterology and Hepatology
Adverse Outcomes: Why Bad Things Happen to Good People
Medical Therapy for Refractory Pediatric Crohn’s Disease
Challenges of NIH Funding for Young Investigators: How the AGA Is Filling the Gap via the AGA Research Foundation  Timothy C. Wang, Rhonda F. Souza  Clinical.
The Role of Psychosocial Care in Adapting to Health Care Reform
Presentation transcript:

A Point-of-Care Paper-based Fingerstick Transaminase Test: Toward Low-cost “Lab-on- a-Chip” Technology for the Developing World  Nira R. Pollock, Donn Colby, Jason P. Rolland  Clinical Gastroenterology and Hepatology  Volume 11, Issue 5, Pages 478-482 (May 2013) DOI: 10.1016/j.cgh.2013.02.022 Copyright © 2013 AGA Institute Terms and Conditions

Figure 1 Schematic of the paper-based AST/ALT test design and protocol. (A) The device consists of 2 layers of similarly patterned paper, a plasma separation membrane, and a laminated cover of polyester film. (B and C) A drop of whole blood (either a fingerstick specimen or 30 μL of a specimen obtained by venipuncture) is applied to the back of the device. Red and white blood cells are filtered out by the plasma separation membrane, whereas plasma wicks to the 5 detection zones through patterned hydrophobic channels in the paper (B). After 15 minutes, the AST and ALT test zones are matched to a color read guide (C) to obtain a concentration value. Results are interpreted as being within 1 of 3 bins of values: <3× ULN (ULN defined as 40 U/L), 3–5× ULN, or >5× ULN. (D) Detailed schema of the paper-based transaminase test and possible colorimetric readouts for the 5 zones (i–v). A schematic of test and control zones (before receiving a sample) is shown in the center of the figure. (i) AST test zone: low/normal AST values (<80 U/L) result in a dark blue color, whereas high AST values (>200 U/L) result in a bright pink color. (ii) ALT test zone: low/normal ALT values (<60 U/L) result in a yellow color, whereas high ALT values (>200 U/L) result in a deep red color. (iii) ALT negative control zone: a change from white to yellow indicates appropriate device activation; in the event of sample hemolysis, the zone becomes orange/red, and the device is read as invalid. (iv) AST negative control zone: the baseline blue color remains unchanged if dye chemistry is functioning properly, whereas the zone becomes bright pink in the event of nonspecific dye reaction, and the device is read as invalid. (v) AST positive control zone: the zone changes from blue to pink if AST reagents are functioning properly but remains dark blue if either the reagents are not functioning or the zone is not activated, in which case the device is read as invalid. From Pollock NR, et al. A paper-based multiplexed transaminase test for low-cost, POC liver function testing. Sci Transl Med 2012;4:152ra29. Reprinted with permission from AAAS. Clinical Gastroenterology and Hepatology 2013 11, 478-482DOI: (10.1016/j.cgh.2013.02.022) Copyright © 2013 AGA Institute Terms and Conditions